Partner
Jennifer Roscetti, leader of Finnegan’s chemical and metallurgical practices, focuses on patent litigation before U.S. district courts and the U.S. International Trade Commission (ITC). She also represents clients before the U.S. Court of Appeals for the Federal Circuit. Her practice encompasses a range of technologies primarily focused on chemical subject matter such as pharmaceuticals, cosmetics, and specialty chemicals. Jennifer was recognized by LMG Life Sciences as Hatch-Waxman Litigator of the Year, Branded.
Jennifer has particular experience in representing pharmaceutical patent holders in Abbreviated New Drug Application (ANDA) litigations for blockbuster pharmaceuticals. She has had key responsibilities in all aspects of federal district court litigations, from the initial pleading stage through discovery, motions, claim construction, and trial. She also provides strategic guidance to clients on infringement, validity and enforceability issues.
Jennifer’s proficiencies in the chemical area are supported by industry and research experience. Prior to her legal career, she worked as process design engineer for ExxonMobil Chemical Company and as a process engineer for E.I. du Pont de Nemours and Company in the Teflon® division. Jennifer also engaged in research on anti-cancer drugs in the College of Pharmacy at the University of Kentucky.
Jennifer regularly lectures in the United States and abroad concerning potential challenges and opportunities for the pharmaceutical and biotechnology industries in navigating recent developments in U.S. patent law. She serves as an adjunct professor in Patent Law and Advanced Topics in Patent Policy at Howard University of Law. Jennifer was shortlisted for the Life Sciences Lawyer of the Year at the 2023 Women in Business Law Awards, which recognizes leading women practitioners from over 30 practice areas.
Jennifer previously served on the firm’s management committee.
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Represented Pronova in Hatch-Waxman patent litigation concerning multiple ANDAs for generic versions of drug Lovaza®, resulting in judgment of patent infringement, validity, and enforceability in Pronova's favor.
1:09-cv-00286, 1:10-cv-00800, D. Del., Judges Farnan, Robinson, Thynge
12-1498, -1499, Fed. Cir., Judges Dyk, O'Malley, Wallach
Grünenthal GmbH v. Teva Pharmaceuticals
Represented Grünenthal GmbH in Hatch-Waxman litigations against several defendants relating to abuse-deterrent formulations of Opana®.
1:12-cv-08060, S.D.N.Y., Judges Griesa, Daniels, Gorenstein
Ariad Pharmaceuticals v. Eli Lilly and Company
Assisted in representing Eli Lilly in district court and Federal Circuit in action to prevent generic competition with respect to osteoporosis drug Evista®. Two of three patent families in suit found valid and infringed.
08-1248, Fed. Cir., Judges Michel, Newman, Mayer, Lourie, Rader, Bryson, Gajarsa, Linn, Dyk, Prost, Moore
1:02-cv-11280, D. Mass., Judge Zobel
AbbVie Inc. et al v. Alvotech hf.
1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee
Cambria Company LLC v. Cosentino SA
6:20-cv-00894, -00895, -00896, -00897, W.D. Tex., Judge Albright
6:20-cv-01080, W.D. Tex., Judge Albright
IPR2021-00214, -00215, -00216; PGR2021-00010, -00090, PTAB, Judges Kalan, Ross, Kaiser
Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.
Representing Bial in district court Hatch-Waxman litigation involving the anti-epileptic drug Aptiom®.
1:18-cv-00304, D. Del., Judges Connolly, Burke
Event
How and Why to Litigate Before the Unified Patent Court How and Why to Litigate Before the Unified Patent Court
October 19, 2022
Webinar
Event
Managing Global Patent & Trademark Litigation Managing Global Patent & Trademark Litigation
June 16, 2021
Webinar
Press Release
Finnegan Wins Big at the 2024 LMG Life Sciences Americas Awards Finnegan Wins Big at the 2024 LMG Life Sciences Americas Awards
September 6, 2024
LMG Life SciencesAward/Ranking
Finnegan Shortlisted for 14 LMG Life Sciences 2024 Americas Awards Finnegan Shortlisted for 14 LMG Life Sciences 2024 Americas Awards
July 18, 2024
LMG Life SciencesAward/Ranking
Finnegan Shortlisted for the Women in Business Law Awards Americas 2023 Finnegan Shortlisted for the Women in Business Law Awards Americas 2023
April 6, 2023
Women in Business LawAnnouncement
Finnegan Announces 2021 Mentors of the Year Finnegan Announces 2021 Mentors of the Year
December 28, 2021
Commentary
How to Beat the Crowd When Chasing Defensive Patent Work How to Beat the Crowd When Chasing Defensive Patent Work
October 18, 2019
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.